Nomura Asset Management CO LTD Adaptive Biotechnologies Corp Transaction History

Nomura Asset Management CO LTD

15 transactions

Quarter	Operation	Price Per share
Q4 2023 Feb 09, 2024	BUY	$3.46 - $5.33 $0 - $0
Q3 2023 Nov 03, 2023	BUY	$5.07 - $8.44 $0 - $0
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $0 - $0
Q1 2023 May 11, 2023	BUY	$7.8 - $10.11 $0 - $0
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $0 - $0
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$6.5 - $12.67 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$6.5 - $12.67 $0 - $0
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $0 - $0
Q1 2022 May 13, 2022	BUY	$10.12 - $28.9 $0 - $0
Q4 2021 Feb 01, 2022	BUY	$25.17 - $36.85 $0 - $0
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $0 - $0
Q2 2021 Aug 06, 2021	BUY	$32.22 - $44.59 $0 - $0
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $0 - $0
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $0 - $0

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.